Setting new standards in information exchange for the pharmaceutical and biotech industry
Rational Combinations 360˚ Preview by CRI
September 11, 2018
In his preview for upcoming Rational Combinations 360˚ event, Arthur N Brodsky, PhD of the Cancer Research Institute, explains the role of the conference in driving the discovery of more combination therapies by “bringing together researchers, physicians, industry executives, and investors among others in the oncology space” to “foster innovative strategies to help maximize the potential of immunotherapy combinations.” The hope of the conference, as explained by the co-chairs, is to discover more combination immunotherapies that lead to more patient success in this growing field. This objective is achieved through the 360 approach of bring together all of the stakeholders in one place which enables networking across the spectrum and ultimately leads to new collaborations.
Read the full preview here.